Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

Abstract

BACKGROUND: All-trans-retinoic acid induces complete remission in acute promyelocytic leukemia. However, it is not clear whether induction therapy with all-trans-retinoic acid is superior to chemotherapy alone or whether maintenance treatment with all-trans-retinoic acid improves outcome. METHODS: Three hundred forty-six patients with previously untreated acute promyelocytic leukemia were randomly assigned to receive all-trans-retinoic acid or daunorubicin plus cytarabine as induction treatment. Patients who had a complete remission received consolidation therapy consisting of one cycle of treatment identical to the induction chemotherapy, then high-dose cytarabine plus daunorubicin. Patients still in complete remission after two cycles of consolidation therapy were then randomly assigned to maintenance treatment with all-trans-retinoic acid or to observation. RESULTS: Of the 174 patients treated with chemotherapy, 120 (69 percent) had a complete remission, as did 124 of the 172 (72 percent) given all-trans-retinoic acid (P=0.56). When both induction and maintenance treatments were taken into account, the estimated rates of disease-free survival at one, two, and three years were 77, 61, and 55 percent, respectively, for patients assigned to chemotherapy then all-trans-retinoic acid; 86, 75, and 75 percent for all-trans-retinoic acid then all-trans-retinoic acid; 75, 60, and 60 percent for all-trans-retinoic acid then observation; and 29, 18, and 18 percent for chemotherapy then observation. By intention-to-treat analysis, the rates of overall survival at one, two, and three years after entry into the study were 75, 57, and 50 percent, respectively, among patients assigned to chemotherapy, and 82, 72, and 67 percent among those assigned to all-trans-retinoic acid (P= 0.003). CONCLUSIONS: All-trans-retinoic acid as induction or maintenance treatment improves disease-free and overall survival as compared with chemotherapy alone and should be included in the treatment of acute promyelocytic leukemia.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199710093371501

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 38 references

Research works printed but not linked: 5

  1. Ohno R, 1993, Leukemia, 7, 1722
  2. Gallagher RE, 1997, Blood, 90, 1656
  3. Wiley JS, 1995, Leukemia, 9, 774
  4. Chen GQ, 1996, Leukemia, 10, 825
  5. Eardley AM, 1994, Leukemia, 8, 934

Cited by

See all 1,073

Metadata

Authors
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., & Wiernik, P. H.
Affiliations
  • Northwestern University (US)
  • Dana-Farber Cancer Institute (US)
  • University of Maryland, Baltimore (US)
  • University of Washington (US)
  • Canadian Cancer Trials Group (CA)
  • University of New Mexico (US)
  • Roswell Park Comprehensive Cancer Center (US)
  • University of Rochester (US)
  • Albert Einstein College of Medicine (US)
Venue
New England Journal of Medicine
Published
1997-10-09
Volume
337
Issue
15
Pages
1021-1028
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2334200141
Cited by
1,073
References
38
Citations by year
2026: 10 · 2025: 14 · 2024: 20 · 2023: 16 · 2022: 18 · 2021: 20 · 2020: 20 · 2019: 21 · 2018: 28 · 2017: 34 · 2016: 31 · 2015: 36 · 2014: 55 · 2013: 38 · 2012: 37
FWCI
18.96
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
Keywords
all-trans retinoic acid, acute promyelocytic leukemia, daunorubicin, cytarabine, induction chemotherapy, maintenance therapy, complete remission, disease-free survival, overall survival, consolidation therapy
MeSH terms
Adolescent, Adult, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Child, Child, Preschool, Cytarabine, Daunorubicin, Female, Humans, Male, Middle Aged, Remission Induction, Tretinoin, Leukemia, Promyelocytic, Acute, Survival Rate, Treatment Failure, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: All-trans-Retinoic Acid in Acute Promyelocytic Leukemia. https://app.cochat.ai/papers/10.1056/nejm199710093371501
The paper
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., Shepherd, L., Willman, C., Bloomfield, C. D., Rowe, J. M., & Wiernik, P. H. (1997). All-trans-Retinoic Acid in Acute Promyelocytic Leukemia. New England Journal of Medicine. https://doi.org/10.1056/nejm199710093371501

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.